Date: 2/5/2008Length: 00:18:17
Size: 8.37MB
Thought Leader: Natalie Douglas, CEO, IDIS
In this episode, Natalie Douglas provides an introduction to named patient programs, describes the factors that motivate pharmaceutical and biotech companies to implement these programs, and highlights the benefits to the patient as well as the sponsoring company.
Play Full Podcast
Download Related White Paper
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
No comments:
Post a Comment